Correction of stromal cell defect after bone marrow transplantation in aplastic anaemia

J Scopes, M Ismail, KJ Marks… - British journal of …, 2001 - Wiley Online Library
J Scopes, M Ismail, KJ Marks, TR Rutherford, GS Draycott, C Pocock, EC Gordon‐Smith…
British journal of haematology, 2001Wiley Online Library
Defects in stromal cell function have been demonstrated in a number of aplastic anaemia
(AA) patients. Here we have studied a patient with severe AA and abnormal stromal cell
function who underwent bone marrow transplantation (BMT). The objective of this study was
to investigate the timing and the mechanism of correction of the stromal defect after
transplantation. The patient, a 25‐year‐old woman with severe AA, underwent BMT from her
brother. BM was obtained from the patient on five occasions: 2 weeks pre BMT, and 3, 8, 16 …
Defects in stromal cell function have been demonstrated in a number of aplastic anaemia (AA) patients. Here we have studied a patient with severe AA and abnormal stromal cell function who underwent bone marrow transplantation (BMT). The objective of this study was to investigate the timing and the mechanism of correction of the stromal defect after transplantation. The patient, a 25‐year‐old woman with severe AA, underwent BMT from her brother. BM was obtained from the patient on five occasions: 2 weeks pre BMT, and 3, 8, 16 and 21 months post BMT. Stromal cells were grown to confluence and recharged with purified CD34+ cells from normal donors. The support of such cells, as assessed by weekly colony‐forming assay (CFU) of non‐adherent cells, was compared with that of stromal layers grown from normal BM. A novel technique of combined fluorescence in situ hybridization (FISH) and immunocytochemistry was used to determine the origin of specific stromal cell types on cytospins of stroma post BMT. Stromal function was defective at 2 weeks pre BMT and at 3 months post BMT, but returned to normal at 8 and 16 months post BMT. At 21 months post BMT, stromal fibroblasts and endothelial cells were shown to be of recipient origin, and macrophages and T cells were of donor origin. We present here evidence in a case of severe AA for defective stromal function before BMT and delayed normalization of function after BMT. This correlated with engraftment of donor macrophages and T cells, but not fibroblasts and endothelial cells.
Wiley Online Library